| 000 | 00990 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250517050419.0 | ||
| 264 | 0 | _c20160620 | |
| 008 | 201606s 0 0 eng d | ||
| 022 | _a1945-4589 | ||
| 024 | 7 |
_a10.18632/aging.100795 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYang, Chunzhang | |
| 245 | 0 | 0 |
_aHypoxia and glioblastoma therapy. _h[electronic resource] |
| 260 |
_bAging _cAug 2015 |
||
| 300 |
_a523-4 p. _bdigital |
||
| 500 | _aPublication Type: Editorial | ||
| 650 | 0 | 4 |
_aAngiogenesis Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aBevacizumab _xtherapeutic use |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 |
_aGlioblastoma _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoxia _xmetabolism |
| 650 | 0 | 4 |
_aHypoxia-Inducible Factor 1 _xmetabolism |
| 700 | 1 | _aHong, Christopher S | |
| 700 | 1 | _aZhuang, Zhengping | |
| 773 | 0 |
_tAging _gvol. 7 _gno. 8 _gp. 523-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.18632/aging.100795 _zAvailable from publisher's website |
| 999 |
_c25193135 _d25193135 |
||